A Novel Convergent Synthesis of the Potent Antiglaucoma Agent Tafluprost
AbstractTafluprost (AFP-168, 5) is a unique 15-deoxy-15,15-difluoro-16-phenoxy prostaglandin F2α (PGF2α) analog used as an efficacious ocular hypotensive agent in the treatment of glaucoma and ocular hypertension, as monotherapy, or as adjunctive therapy to β-blockers. A novel convergent synthesis of 5 was developed employing Julia–Lythgoe olefination of the structurally advanced prostaglandin phenylsulfone 16, also successfully applied for manufacturing of pharmaceutical grade latanoprost (2), travoprost (3) and bimatoprost (4), with an aldehyde ω-chain synthon 17. The use of the same prostaglandin phenylsulfone 16, as a starting material in parallel syntheses of all commercially available antiglaucoma PGF2α analogs 2–5, significantly reduces manufacturing costs resulting from its synthesis on an industrial scale and development of technological documentation. Another key aspect of the route developed is deoxydifluorination of a trans-13,14-en-15-one 30 with Deoxo-Fluor. Subsequent hydrolysis of protecting groups and final esterification of acid 6 yielded tafluprost (5). The main advantages are the preparation of high purity tafluprost (5) and the application of comparatively cheap reagents. The preparation and identification of two other tafluprost acid derivatives, tafluprost methyl ester (32) and tafluprost ethyl amide (33), are also described. View Full-Text
- Supplementary File 1:
PDF-Document (PDF, 241 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Krupa, M.; Chodyński, M.; Ostaszewska, A.; Cmoch, P.; Dams, I. A Novel Convergent Synthesis of the Potent Antiglaucoma Agent Tafluprost. Molecules 2017, 22, 217.
Krupa M, Chodyński M, Ostaszewska A, Cmoch P, Dams I. A Novel Convergent Synthesis of the Potent Antiglaucoma Agent Tafluprost. Molecules. 2017; 22(2):217.Chicago/Turabian Style
Krupa, Małgorzata; Chodyński, Michał; Ostaszewska, Anna; Cmoch, Piotr; Dams, Iwona. 2017. "A Novel Convergent Synthesis of the Potent Antiglaucoma Agent Tafluprost." Molecules 22, no. 2: 217.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.